HONG KONG, July 02, 2026 (GLOBE NEWSWIRE) — Guest Supply Asia today announced a licensing agreement with HAAN to manufacture and distribute HAAN-branded personal care products for hotels across Asia Pacific. The agreement combines HAAN’s design-led, refillable approach to personal care with Guest Supply’s product development, manufacturing, distribution and service capabilities for hotel operators. It will give hospitality customers easier access to premium, operationally ready products. HAAN is a travel-centric personal care brand known for practical, portable products designed for life on the go. Its formulas emphasize clean, natural and vegan ingredients, while its refillable systems are intended to help reduce single-use plastic waste. The brand also supports clean-water initiatives by directing a share of profits toward underground...

Latest assays such as 42m @ 6.1% CuEq and 9.8m @ 16.5% CuEq, which demonstrate the outstanding continuity of the high-grade zone, will feed into the impending economic studies KEY POINTSDrilling returns more exceptional results which extend the high-grade core zone and confirm the strong continuity of the mineralisation Given the strength of the results, FireFly will incorporate them into an updated resource model underpinning the economic studies; This means these studies will now be completed in July-August 2026 The results, generated primarily from infill drilling, will be reflected in the Measured & Indicated Resource category; This category is central to the economic studies The results are particularly important because they demonstrate the strong continuity and grade of the high-grade core zone, which will be a key input...

FDA and Telix align on advancement into Part 2 of the ProstACT Global Phase 3 study in the United States. FDA agrees with the clinical protocol and proposed statistical framework across three standard-of-care combination cohorts. Part 2 (randomized cohort) continues to recruit in jurisdictions where the study has regulatory approval.MELBOURNE, Australia and INDIANAPOLIS, July 02, 2026 (GLOBE NEWSWIRE) — Telix Pharmaceuticals (ASX: TLX, NASDAQ: TLX, “Telix”) today announced the successful outcome of a Type B meeting with the United States (U.S.) Food and Drug Administration (FDA) to review the Part 1 safety and dosimetry data and Part 2 protocol design of the ProstACT Global Phase 3 trial of its therapeutic candidate TLX591-Tx (lutetium-177 (177Lu) rosopatamab tetraxetan) in metastatic castration resistant prostate cancer. The...

SHANGHAI, July 01, 2026 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the company has recently entered into a license agreement with Fosun Wanbang Pharma Group (“Fosun Wanbang,” a wholly-owned subsidiary of Fosun Pharma (HKEX: 02196; SSE: 600196). The two parties will cooperate on the development, registration, manufacturing and commercialization of roconkibart (JS005, anti-IL-17A monoclonal antibody) in the Greater China region, which includes the Chinese mainland, Hong Kong Special Administrative Region, Macao Special Administrative Region, and Taiwan. Pursuant to the licensing agreement, Junshi Biosciences will grant Fosun...

Boise, Idaho, July 01, 2026 (GLOBE NEWSWIRE) — Idaho Copper Corporation (“Idaho Copper” and the “Company”) (NYSE American: COPR, COPR WS), a critical minerals developer advancing the flagship CuMo copper-molybdenum-silver project in Idaho, today announced the pricing of an underwritten public offering of common stock and warrants at a price of $4.85 per share, for gross proceeds of approximately $18,000,000, before deducting underwriting discounts and offering expenses. In addition, Idaho Copper has granted the underwriters a 45-day option to purchase up to an additional 556,800 shares of common stock and/or warrants to cover over-allotments, if any. The Company intends to use the proceeds for the completion of an updated Preliminary Economic Assessment, the first phase of preliminary work of a Prefeasibility Study, and general...

HOUSTON, July 01, 2026 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) today provided a summary unaudited statement of assets and liabilities and announced its net asset value and asset coverage ratios under the Investment Company Act of 1940 (the “1940 Act”) as of June 30, 2026. As of June 30, 2026, the Company’s net assets were $2.7 billion, and its net asset value per share was $16.02. As of June 30, 2026, the Company’s asset coverage ratio under the 1940 Act with respect to senior securities representing indebtedness was 633% and the Company’s asset coverage ratio under the 1940 Act with respect to total leverage (debt and preferred stock) was 492%.STATEMENT OF ASSETS AND LIABILITIESJUNE 30, 2026   // (UNAUDITED)     (in millions)Investments   $ 3,827.9  Cash and...

NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) — Viking Acquisition Corp. II (NYSE: VII U) (the “Company”), a Cayman Islands exempted company, announced today that it priced its initial public offering of 20,000,000 units at $10.00 per unit. The units are expected to be listed on the New York Stock Exchange (“NYSE”) and trade under the ticker symbol “VII U” beginning on July 2, 2026. Each unit consists of one (1) Class A ordinary share and one-third (1/3) of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. Only whole warrants will be exercisable. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on NYSE under...

NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) — Meridian3 Industrials Acquisition Corp (the “Company”) announced today the pricing of its initial public offering of 17,500,000 units at a price of $10.00 per unit. The units will be listed on The Nasdaq Global Market, or Nasdaq, and trade under the ticker symbol “MIACU” with trading expected to begin on July 2, 2026. Each unit consists of one Class A ordinary share of the Company and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share of the Company at a price of $11.50 per share, subject to certain adjustments. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “MIAC” and “MIACW,” respectively. The offering...